EUVIMEDEUVIMED entdecken
Kohortenstudie

Survival Following Neoplastic Disease in Individuals With Neurofibromatosis 1—A National Danish Population‐Based Cohort Study

Mia Aagaard Doherty iD, Kathrine Grell, Hanne Hove, Mette M Handrup, John R Østergaard, Anja Krøyer, Thomas T Nielsen, Henrik Hjalgrim iD, John J Mulvihill, Jan Wohlfahrt, Henrik Hasle, Cecilie Ejerskov und 1 weitere

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70608 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Mia Aagaard Doherty und 12 weiteren Autor:innen. Beteiligte Einrichtung: Childhood Cancer Research Group, Danish Cancer Institute, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neoplasms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Novo Nordisk Fonden, Danish Cancer Society, Kræftens Bekæmpelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Population‐based evidence on cancer survival in individuals with neurofibromatosis 1 (NF1) remains limited. We compared survival following a first neoplasm in individuals with NF1 to that of the general Danish population and stratified on age, sex, and potential survival‐related factors, including cancer stage and comorbidity. Using the Danish Cancer Registry, we identified 428 individuals with NF1 and 392,885 without NF1, all diagnosed with a first neoplasm (1977–2022). We estimated survival using Kaplan–Meier methods, assessed neoplastic and nonneoplastic mortality, and evaluated prior inpatient disease burden in adults (aged 20–69 years) based on hospital diagnoses 10 years to 6 months before neoplasm diagnosis. Among children (aged 1–19 years), NF1 was overall associated with better 5‐year survival (NF1: 87.3% [81.1%–93.5%], non‐NF1: 78.7% [77.9%–79.6%]), due to better survival following central nervous system (CNS) neoplasms. In adults, 5‐year survival was lower in NF1 compared to the general population (57.0% [51.3%–62.6%] vs. 69.2% [69.0%–69.3%]). NF1 adults more often presented with stage IV breast (17.2% vs. 6.3%) and gastrointestinal cancers (52.5% vs. 37.7%). Among adults with no prior inpatient diagnoses, 5‐year survival was poorer in NF1 (60.1% [51.3%–68.9%] vs. 72.1% [71.9%–72.3%]). Five‐year neoplastic mortality was higher in NF1 adults (39.4% [33.8%–45.0%] vs. 27.7% [27.6%–27.9%]). In conclusion, individuals with NF1, particularly adults, have poorer cancer survival than the general population. Differences in cancer type and stage at diagnosis contribute but do not fully explain the excess mortality, indicating that factors beyond general health status may play a role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1NeoplasmsHumansFemaleDenmarkAdultMaleMiddle AgedAgedAdolescentChild, PreschoolChildYoung AdultInfantCohort StudiesRegistriesKaplan-Meier Estimate

Stichwörter der Autor:innen

Neurofibromatosis 1cancer survivalcomorbiditynationwide cohort studypopulation‐based

Autor:innen und Institutionen

  • Childhood Cancer Research Group, Danish Cancer Institute, Copenhagen, Denmark.
  • Statistics and Data Analysis, Danish Cancer Institute, Copenhagen, Denmark.
  • Department of Pediatrics and Adolescent Medicine, Centre for Rare Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Pediatric and Adolescent Medicine, Centre for Rare Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Haematology Research Group, Danish Cancer Institute, Copenhagen, Denmark.
  • Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

ORCID-Profile: Mia Aagaard Doherty, Henrik Hjalgrim, Line Kenborg

Förderung

  • Novo Nordisk Fonden
  • Danish Cancer Society
  • Kræftens Bekæmpelse

Zitieren

APA

Doherty, M. A., Grell, K., Hove, H., Handrup, M. M., Østergaard, J. R., Krøyer, A., Nielsen, T. T., Hjalgrim, H., Mulvihill, J. J., Wohlfahrt, J., Hasle, H., Ejerskov, C., & Kenborg, L. (2026). Survival Following Neoplastic Disease in Individuals With Neurofibromatosis 1—A National Danish Population‐Based Cohort Study. International Journal of Cancer. https://doi.org/10.1002/ijc.70608

Vancouver

Doherty MA, Grell K, Hove H, Handrup MM, Østergaard JR, Krøyer A, et al. Survival Following Neoplastic Disease in Individuals With Neurofibromatosis 1—A National Danish Population‐Based Cohort Study. International Journal of Cancer. 2026. doi:10.1002/ijc.70608

BibTeX
@article{Doherty2026,
  author = {Doherty, Mia Aagaard and Grell, Kathrine and Hove, Hanne and Handrup, Mette M and Østergaard, John R and Krøyer, Anja and Nielsen, Thomas T and Hjalgrim, Henrik and Mulvihill, John J and Wohlfahrt, Jan and Hasle, Henrik and Ejerskov, Cecilie and Kenborg, Line},
  title = {Survival Following Neoplastic Disease in Individuals With Neurofibromatosis 1—A National Danish Population‐Based Cohort Study},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70608}
}
Kostenlos starten →